Mankind Pharma Shares Jump Nearly 8% After Q2 Profit Rises 39%
Mint

Mankind Pharma's September-quarter performance was supported by 15.9% growth in domestic pharmaceutical revenue, excluding consumer healthcare, to Rs 3,428 crore. However, performance in consumer healthcare will remain key monitorable.
Summary from NDTV Profit
Read the full story on NDTV ProfitFollow








